Technology reveal · Coming soon
Vascular access is about to change.
One of the most common procedures in healthcare has remained fundamentally unchanged for decades. We think it deserves better.
We’ve spent years rethinking it. Soon, we’ll show you how.
27+ granted patents $2.5M+ raised Built with clinical and engineering expertise
A persistent problem
One of healthcare’s most commonly used devices still fails far too often.
Peripheral IV catheters are placed across nearly every care setting, yet premature failure remains a persistent and widespread challenge.
Rates vary by population, setting, device, study design, and definition of failure.Rates vary by population, setting, and study design.
What failure means
When a line fails,
the work starts again.
Access is lost.
A functioning line may need to be removed.
Therapy is interrupted.
Medication or fluid delivery may pause while access is restored.
Another procedure may be required.
Another catheter. Another insertion attempt. Another experience for the patient.
Clinical resources are consumed.
Assessment. Troubleshooting. Removal. Documentation. Replacement. Monitoring.
When vascular access fails, the impact extends far beyond the device.
System impact
One failed line is a clinical event. Millions become a system-wide burden.
The cost of premature vascular access failure extends beyond the catheter itself. Replacement procedures can require additional supplies, clinician time, documentation, workflow disruption, and therapy interruption.
Estimated direct annual burden associated with peripheral IV failure and replacement.
Potential repeat insertions associated with premature failure annually.
Potential nursing hours consumed by repeat vascular access procedures and associated workflow.
Illustrative estimates based on published failure rates, annual utilization, and modeled resource assumptions.
At this scale, even incremental improvements can matter.
The root problem
The catheter is only part of the system.
A peripheral IV does not exist in isolation. It interacts continuously with the patient, dressing, extension set, surrounding materials, clinician workflow, movement, therapy, and time.
Yet many technologies surrounding vascular access continue to address individual elements separately.
Vasonics started by looking at the system differently.
Years in development
Why we spent years on a problem most people never see.
Because failure is common.
Premature peripheral IV failure remains a persistent, widespread challenge across nearly every care setting.
Because patients feel it.
Every failed line can mean another insertion, interrupted therapy, and another experience for the patient.
Because it was never solved as one system.
Vascular access has been addressed one component at a time. We set out to rethink it as a whole.
Not another
peripheral IV product.
A new foundation for vascular access.
Vasonics is developing an integrated vascular access platform designed around the realities of how peripheral IV therapy is actually delivered.
Rather than viewing vascular access as a collection of isolated components, Vasonics approaches it as a connected system.
Under wraps. For now.
Platform principles
Designed as one system.
Adaptive stabilization
A new approach to stabilization, designed around the physical realities of vascular access.
Site environment
Designed with the access site and therapy environment in mind.
Workflow
Designed around how vascular access is actually used in clinical care.
Intelligence
Designed for a future where vascular access can become more measurable, connected, and understood.
What’s coming is
more than a device.
Every vascular access episode creates information.
Most of that information has never been connected.The intelligence layer for vascular access
VIRA™
From vascular access to vascular intelligence.
VIRA is the digital intelligence platform being developed alongside the vCell ecosystem.
Its purpose is to create a structured understanding of the vascular access journey by connecting information that is traditionally fragmented across procedures, devices, workflows, clinical documentation, and outcomes.
The goal is not simply to collect more data.It is to make vascular access more understandable.
The VIRA concept
Every line has a story.
A vascular access episode can contain information about insertion, device characteristics, therapy, time, movement, interventions, clinical context, device changes, replacement, completion, and outcomes.
VIRA is being built to provide the architecture for understanding those episodes at scale.
Intelligence model
Experience becomes knowledge.
Information becomes meaningful when it is structured, connected, and understood across every episode.
Capture
Create structured information around vascular access episodes.Structure every episode.
Connect
Bring together relevant context across the vascular access journey.Link context across the journey.
Understand
Analyze patterns across episodes, populations, devices, workflows, and outcomes.See patterns across episodes.
Learn
Build an expanding evidence base capable of supporting research, operational insight, and future intelligence.Grow the evidence base.
Every episode can add to what we know.
VIRA is being built to turn vascular access experience into vascular access knowledge.VIRA + Research
A new foundation for vascular access research.
Vascular access generates an enormous amount of clinical data across millions of procedures. Yet understanding what happens across those episodes remains difficult.
VIRA is being built to support structured evidence generation, longitudinal analysis, and deeper study of vascular access performance.
Built toward future collaboration with
Clinical researchersVascular access teamsHealth systemsDevice developersQuality teamsStrategic partnersWhat happens when vascular access becomes measurable?
What patterns have we been missing?
What can millions of access episodes teach us?
Can we better understand why one episode differs from another?
Can vascular access evolve through continuous evidence instead of isolated observations?
VIRA is being built to explore those questions.
The vCELL ecosystem
One ecosystem.
Vasonics is building toward a future where vascular access technology and vascular access intelligence evolve together.
Why this matters
Vascular access may be routine.
For the patient,
it never is.
A peripheral IV can be the pathway through which a patient receives hydration, medication, antibiotics, chemotherapy, anesthesia, or other essential therapy.
Behind every line is a person depending on that access.
Built deliberately
Built on more than an idea.
Vasonics has developed, protected, tested, and refined its approach to vascular access. Built quietly.
Partnerships
Help shape what comes next.
Vasonics is engaging with clinicians, vascular access leaders, health systems, researchers, strategic partners, and organizations interested in advancing vascular access.
Clinical
Research, evaluation, and future pilot collaboration.
Strategic
Technology, manufacturing, commercialization, and ecosystem partnerships.
Investment
Supporting the next stage of Vasonics’ development.
The reveal is coming
You’ve seen the problem.
Soon, you’ll see what we’ve built.
Vasonics has developed a new approach to vascular access. We’re getting closer to sharing it.
- In development
- Validation
- Reveal